Skip to main content

Table 1 Demographic characteristics of the cohort (n = 187)

From: Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts

Characteristics mean ± SD or n (%)
Age at enrollment (years) 53.0 ± 12.6
Age at diagnosis (years) 45.8 ± 12.4
Sex
 Male 103 (55.1%)
 Female 84 (44.9%)
Race
 White 132 (70.6)
 African American 32 (17.1)
 Asian 3 (1.6)
 American Indian or Alaska Native 1 (0.5)
 Choose not to answer 19 (10.2)
Body mass index (kg/m2) 31.2 ± 7.1
Smoking status
 Never 101 (54.0)
 Former 71 (38.0)
 Current 15 (8.0)
Family history of sarcoidosis 16 (9.0)
Use of anti-inflammatory agents
 Treated ≥1 month 133 (71.1)
 Treated < 1 month or never 54 (28.9)
Pulmonary function tests
 FEV1 (% predicted) 80.0 ± 23.5
 FVC (% predicted) 85.2 ± 21.2
 FEV1:FVC ratio 74.4 ± 11.5
 TLC (% predicted) 92.7 ± 17.3
 DLCO (% predicted) 89.5 ± 26.0